These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18771092)

  • 1. Evolution of viruses and their impact on human life: HIV-1 subgroup M.
    Becker Y
    APMIS Suppl; 2008; (124):7-13. PubMed ID: 18771092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is HIV-1 evolving to a less virulent form in humans?
    Ariën KK; Vanham G; Arts EJ
    Nat Rev Microbiol; 2007 Feb; 5(2):141-51. PubMed ID: 17203103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spreading of HIV-1 infection in the human organism is caused by fractalkine trafficking of the infected lymphocytes--a review, hypothesis and implications for treatment.
    Becker Y
    Virus Genes; 2007 Apr; 34(2):93-109. PubMed ID: 17151939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics to study macrophage response to viral infection.
    Nyman TA; Matikainen S
    J Proteomics; 2018 May; 180():99-107. PubMed ID: 28647517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune system damage in human immunodeficiency virus type 1 infection. Implications for acquired immunity and vaccine design.
    Howie S; Ramage R; Hewson T
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 2):S141-5. PubMed ID: 11029383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus from 1959 sample marks early years of HIV.
    Balter M
    Science; 1998 Feb; 279(5352):801. PubMed ID: 9480549
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV-1 adaptation to HLA: a window into virus-host immune interactions.
    Carlson JM; Le AQ; Shahid A; Brumme ZL
    Trends Microbiol; 2015 Apr; 23(4):212-24. PubMed ID: 25613992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection.
    Horton H; Havenar-Daughton C; Lee D; Moore E; Cao J; McNevin J; Andrus T; Zhu H; Rubin A; Zhu T; Celum C; McElrath MJ
    J Virol; 2006 Oct; 80(19):9779-88. PubMed ID: 16973582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-macrophage interactions at the cellular and molecular level.
    Khati M; James W; Gordon S
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):367-78. PubMed ID: 11798135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gulliver's travels in HIVland.
    Weiss RA
    Nature; 2001 Apr; 410(6831):963-7. PubMed ID: 11309625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural protection against HIV-1 infection provided by HIV-2.
    Travers K; Mboup S; Marlink R; Guèye-Nidaye A; Siby T; Thior I; Traore I; Dieng-Sarr A; Sankalé JL; Mullins C
    Science; 1995 Jun; 268(5217):1612-5. PubMed ID: 7539936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosscurrents in HIV-1 evolution.
    Blankson JN; Bailey JR; Siliciano RF
    Nat Immunol; 2006 Feb; 7(2):121-2. PubMed ID: 16424885
    [No Abstract]   [Full Text] [Related]  

  • 13. The HIV/AIDS pandemic--virology update.
    van Rensburg EJ
    SADJ; 2002 Dec; 57(11):438, 440. PubMed ID: 12674858
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges in the development of an HIV-1 vaccine.
    Barouch DH
    Nature; 2008 Oct; 455(7213):613-9. PubMed ID: 18833271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A point of view: HIV-1/AIDS is an allergy but CpG ODN treatments may inhibit virus replication and reactivate the adaptive immunity--hypothesis and implications.
    Becker Y
    Virus Genes; 2005 Jan; 30(1):127-31. PubMed ID: 15744571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of multiple infection of cells on the evolutionary dynamics of HIV in vivo: implications for host adaptation mechanisms.
    Wodarz D; Levy DN
    Exp Biol Med (Maywood); 2011 Aug; 236(8):926-37. PubMed ID: 21768164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the origin and evolution of the human immunodeficiency virus (HIV).
    Holmes EC
    Biol Rev Camb Philos Soc; 2001 May; 76(2):239-54. PubMed ID: 11396848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.
    Belyakov IM; Ahlers JD
    Curr Top Microbiol Immunol; 2012; 354():157-79. PubMed ID: 21203884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model.
    Sato K; Misawa N; Takeuchi JS; Kobayashi T; Izumi T; Aso H; Nagaoka S; Yamamoto K; Kimura I; Konno Y; Nakano Y; Koyanagi Y
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of proviral accessory genes between long-term nonprogressors and progressors of human immunodeficiency virus type 1 infection.
    Yamada T; Iwamoto A
    Arch Virol; 2000; 145(5):1021-7. PubMed ID: 10881687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.